SystImmune said the NMPA cleared the EGFR × HER3 bispecific ADC for adults with recurrent or metastatic esophageal squamous cell carcinoma after prior platinum chemotherapy and PD-1/PD-L1 therapy.
verifying reliability
No specialized terms available for this topic.